Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
VivaFix™ Cell Viability Assays Launched
Monday, November 24, 2014
Bio-Rad introduces a simple way to assess the viability of cells for flow cytometry and cell sorting that is compatible with fixation.

Organovo Announces Commercial Release of the exVive3D™ Human Liver Tissue
Friday, November 21, 2014
exVive3D™ human liver tissue for preclinical drug discovery testing.

Bio-Rad Launches Benchtop S3e™ Cell Sorter with AutoGimbal™ Nozzle Alignment System
Thursday, November 20, 2014
Walk-away automation for accurate and reliable cell sorts of one or two populations.

Irvine Scientific Introduces DMSO-Free
Wednesday, November 19, 2014
A chemically-defined cryopreservation solution for mesenchymal stem cells.

PRIME-XV® FreezIS DMSO-Free Launched
Tuesday, November 18, 2014
Irvine Scientific introduces DMSO-Free, chemically-defined cryopreservation solution for mesenchymal stem cells.

Fluorescence-based Mitochondria / Metabolism Assays
Friday, November 14, 2014
Strategic marketing agreement with Luxcel to distribute 96- and 384-well phosphorescence and fluorescence based assays.

Olympus DSX100 Opto-Digital System
Thursday, November 13, 2014
Offers biological imaging with smartphone ease.

Top Ten Pharma Uses Time Saving Fill-it System in Biologics Manufacturing
Friday, November 07, 2014
To assure consistent quality cell banks and reference standards at half the cost.

Bringing Images to Life with CellSens 1.12
Tuesday, October 28, 2014
New Olympus imaging software offers new functions and support for the latest microscopy hardware and life science researchers can now observe and react to the most elusive events taking place within biological samples.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 257
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv